Incidence of arrhythmia in chronic lymphocytic leukemia (CLL) patients treated with ibrutinib: a real-world retrospective analysis from two Italian centers.

被引：0
|
作者：
Murru, Roberta
Innocenti, Idanna
Galitzia, Andrea
Tomasso, Annamaria
Oggianu, Valeria
Laurenti, Luca
La Nasa, Giorgio
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1553534
引用
收藏
页码：S162 / S163
页数：2
相关论文
共 50 条
  • [31] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis Using a Real-World Database
    Liu, Yin
    Chen, Yanfei
    Xiao, Yue
    Huang, Ruijian
    Jiang, Feng
    Yi, Shuhua
    Zhou, Jifang
    BLOOD, 2023, 142
  • [32] Applicability of the Chronic Lymphocytic Leukemia (CLL)-IPI on Patients Treated with Front-Line Ibrutinib in the Real World: The Case for New Prognostic Models
    Brander, Danielle M.
    Rhodes, Joanna
    Pagel, John M.
    Nabhan, Chadi
    Tam, Constantine S.
    Jacobs, Ryan
    Hill, Brian T.
    Lamanna, Nicole
    Lansigan, Frederick
    Shadman, Mazyar
    Ujjani, Chaitra S.
    Skarbnik, Alan P.
    Cheson, Bruce D.
    Pu, Jeffrey J.
    Sehgal, Alison R.
    Barr, Paul M.
    Allan, John N.
    Beach, Douglas F.
    Patel, Bhavisha
    Pickens, Peter V.
    Nasta, Sunita Dwivedy
    Kennard, Kaitlin
    Tuncer, Hande H.
    Koch, Brittany
    Furman, Richard R.
    Mato, Anthony R.
    BLOOD, 2017, 130
  • [33] Outcomes and Clinical Practice Among Patient with Chronic Lymphocytic Leukemia Treated with Ibrutinib in China: A Real-World Experience
    Yang, Shenmiao
    Feng, Ru
    Guo, Xutao
    Li, Zhenling
    Ju, Qianqian
    Dong, Yujun
    Wang, Bingjie
    Zhao, Yu
    Wang, Liang
    Sun, Wanling
    Fang, Fang
    Wang, Liru
    Su, Liping
    Huang, Xiaojun
    BLOOD, 2024, 144 : 7819 - 7820
  • [34] Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax
    Valtis, Yannis K.
    Nemirovsky, David
    Derkach, Andriy
    Sharan, Saumya
    Kabel, Charlene
    Ortiz, Ricardo
    Thompson, Meghan C.
    Roeker, Lindsey E.
    Geyer, Mark B.
    BLOOD ADVANCES, 2024, 8 (22) : 5806 - 5813
  • [35] Real-World Risk of Major Bleeding Events in BTKi-Treated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL)
    Moslehi, Javid J.
    Wahlstrom, Svea K.
    Teschemaker, Anna
    Mackey, Rachel H.
    Devincenzo, Diana
    Carabuena, Leslie A.
    Thompson, Samantha L.
    Gordon, Brittaney-Belle Elizabeth
    Rosenthal, Ning A.
    BLOOD, 2024, 144 : 5109 - 5110
  • [36] Impact of ibrutinib on quality of life in patients with chronic lymphocytic leukemia: preliminary results of real-world experience
    Osorio, Maria J. Mela
    Pavlovsky, Astrid
    Pavlovsky, Carolina
    Fernandez, Isolda
    Massa, Federico Sackmann
    Ferrari, Luciana
    Juni, Mariana
    Riddick, Maximiliano
    Pavlosky, Miguel
    LEUKEMIA & LYMPHOMA, 2020, 61 : 195 - 197
  • [37] Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience
    Laurenti, Luca
    Scarfo, Lydia
    Frustaci, Anna Maria
    Sanna, Alessandro
    Iannella, Emilia
    Caira, Morena
    Finsinger, Paola
    Schifano, Silvia
    Neri, Benedetta
    Molica, Stefano
    Mauro, Francesca Romana
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 621 - 630
  • [38] Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naïve Patients with Chronic Lymphocytic Leukemia: An Italian Healthcare Administrative Database Analysis
    Giulia Ronconi
    Letizia Dondi
    Silvia Calabria
    Carlo Piccinni
    Antonella Pedrini
    Immacolata Esposito
    Nello Martini
    Clinical Drug Investigation, 2021, 41 : 595 - 604
  • [39] Real-world treatment patterns and outcomes of zanubrutinib in chronic lymphocytic leukemia and small lymphocytic leukemia (CLL/SLL)
    Krackeler, Margaret
    Chee, Bryant
    Orchanian, Arthur K.
    Law, Lisa Y.
    Lopez, Alfredo R.
    Buchanan, Susan
    Maglinte, Gregory A.
    Liu, Raymond
    Zhu, Zheng
    Sakoda, Lori C.
    Tavakoli, Jahan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study
    Mauro, Francesca Romana
    Scalzulli, Potito Rosario
    Scarfo, Lydia
    Minoia, Carla
    Murru, Roberta
    Sportoletti, Paolo
    Frigeri, Ferdinando
    Albano, Francesco
    Di Renzo, Nicola
    Sanna, Alessandro
    Laurenti, Luca
    Massaia, Massimo
    Cassin, Ramona
    Coscia, Marta
    Patti, Caterina
    Pennese, Elsa
    Tafuri, Agostino
    Chiarenza, Annalisa
    Galieni, Piero
    Perbellini, Omar
    Selleri, Carmine
    Califano, Catello
    Ferrara, Felicetto
    Cuneo, Antonio
    Murineddu, Marco
    Palumbo, Gaetano
    Scortechini, Ilaria
    Tedeschi, Alessandra
    Trentin, Livio
    Varettoni, Marzia
    Pane, Fabrizio
    Liberati, Anna Marina
    Merli, Francesco
    Morello, Lucia
    Musuraca, Gerardo
    Tani, Monica
    Ibatici, Adalberto
    Regazzoni, Giulia
    Di Candia, Michele
    Palma, Maria
    Arienti, Danilo
    Molica, Stefano
    CANCERS, 2024, 16 (06)
12345